Nearly HALF of cancer patients taking ivermectin + mebendazole saw their tumors DISAPPEAR or SHRINK in the largest ivermectin-cancer study ever conducted. Our findings make sense: over a HUNDRED preclinical studies have identified 12+ anticancer mechanisms of these compounds.